US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Sorrento Therapeutics Inc (SRNE)
Sorrento Therapeutics Inc (SRNE) ニュース

SRNE

Sorrento Therapeutics (SRNE)

Sorrento Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SRNE

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/11/04	06 : 31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/10/28	05 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/09/13	10 : 51	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/08/29	06 : 25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/08/08	05 : 15	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/08/01	19 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/07/13	19 : 26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/06/22	06 : 25	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/06/21	06 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/06/15	22 : 44	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/06/05	22 : 00	GlobeNewswire Inc.	Shanghai Escugen Biotechnology Co., Ltd., a partner of Levena Biopharma, a Sorrento Company, releases positive results from a first-in-human study of ESG401, a TROP2 Antibody Drug Conjugate in patients with locally advanced/metastatic solid tumors at the A	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/05/19	19 : 04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/05/16	04 : 18	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/05/16	01 : 04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/05/13	06 : 29	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/05/09	19 : 03	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/05/03	19 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/04/21	06 : 28	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/04/21	01 : 09	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/04/12	21 : 51	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/04/11	06 : 23	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/04/11	04 : 16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/03/31	19 : 17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/03/21	08 : 54	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/03/20	19 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/03/11	01 : 22	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/03/09	04 : 20	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/02/22	23 : 25	AllPennyStocks.com	Bankruptcy Court Approval Causes Premarket Buying Pressure	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/02/22	07 : 57	PR Newswire (US)	Sorrento Therapeutics, Inc. Receives Court Approval for $75 Million Financing in Chapter 11 Case	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/02/22	06 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SRNE	Sorrento Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:SRNE

1 2 3 4 5 6 7 8 9 10 次へ >>

Ebrd Tf 6,75% Gn25 Huf

Morgan Stanley Finance L...

OptionRoom Token

Sigma Fin.nts15

Societe Generale Effekten

Global Data Centre

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約